ClariVest Asset Management’s Boston Scientific BSX Stock Holding History

ClariVest Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$4.08K	Hold	53	–	–	﹤0.01%	461
2024 Q2	$4.08K	Sell	53 -214	-80%	-$15.7K	﹤0.01%	461
2024 Q1	$18.3K	Buy	267 +37	+16%	+$2.38K	﹤0.01%	384
2023 Q4	$13.3K	Buy	230 +1	+0.4%	+$53	﹤0.01%	391
2023 Q3	$12K	Buy	229 +15	+7%	+$787	﹤0.01%	384
2023 Q2	$12K	Buy	+214	New	+$11.2K	﹤0.01%	376
2018 Q4	–	Sell	-16,263	Closed	-$626K	–	703
2018 Q3	$626K	Sell	16,263 -16,900	-51%	-$590K	0.01%	476
2018 Q2	$1.08M	Buy	33,163 +4,900	+17%	+$148K	0.02%	430
2018 Q1	$772K	Sell	28,263 -1,000	-3%	-$27.2K	0.01%	457
2017 Q4	$726K	Buy	29,263 +16,000	+121%	+$441K	0.01%	455
2017 Q3	$387K	Sell	13,263 -11,100	-46%	-$307K	0.01%	408
2017 Q2	$676K	Hold	24,363	–	–	0.02%	370
2017 Q1	$606K	Buy	24,363 +400	+2%	+$9.73K	0.02%	377
2016 Q4	$518K	Buy	23,963 +4,863	+25%	+$106K	0.01%	398
2016 Q3	$455K	Buy	+19,100	New	+$456K	0.01%	385

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

ClariVest Asset Management's BSX Position: Q3 2024 in Review

ClariVest Asset Management held its Boston Scientific (BSX) position steady in Q3 2024 at 53 shares worth $4.08K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

ClariVest Asset Management first reported a position in BSX in Q3 2016 and has held it in 15 quarters since. The position peaked at $1.08M in Q2 2018. 1,396 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

ClariVest Asset Management held 53 shares of Boston Scientific worth $4.08K as of Q3 2024.
ClariVest Asset Management left its Boston Scientific share count unchanged in Q3 2024.
Boston Scientific made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #461 holding.
ClariVest Asset Management first reported a position in Boston Scientific in Q3 2016 and has held it in 15 quarters since.
ClariVest Asset Management's Boston Scientific position peaked at $1.08M in Q2 2018.
1,396 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.